Table1
Patients’ demographic data
| Group A | Group B | P | |
|---|---|---|---|
| Number | 24 | 27 | |
| Age (year-old) | 71.0 ± 11.2 | 68.9 ± 12.2 | 0.508 |
| Male / Female | 17 / 7 | 18 / 9 | 0.772 |
| APACHE II | 21.0 ± 5.8 | 20.4 ± 6.4 | 0.734 |
| SOFA | 7.3 ± 3.1 | 7.9 ± 3.4 | 0.469 |
| Shock, n (%) | 9 (37.5) | 14 (51.9) | 0.400 |
| Surgical site | |||
| Upper tract | 15 | 12 | 0.162 |
| Lower tract | 8 | 15 | |
| Miscellaneous | 1 | 0 | |
| Drug therapy | |||
| Steroid, n (%) | 5 (20.8) | 11 (40.7) | 0.145 |
| Ventilator settings at the start of the study | |||
| PEEP (cmH2O) | 10.3 ± 2.3 | 9.0 ± 3.2 | 0.116 |
| Peak pressure (cmH2O) | 19.5 ± 4.5 | 18.3 ± 5.7 | 0.426 |
| Respiratory rate | 21.5 ± 6.8 | 22.6 ± 7.7 | 0.584 |
| PaO2 /FiO2 | |||
| At the start of mechanical ventilation | 118 ± 41 | 141 ± 42 | 0.030 |
| At the time after the start of the study | |||
| 0 h | 154 ± 41 | 156 ± 30 | 0.841 |
| 12 h | 223 ± 63 | 166 ± 46 | < 0.001 |
| 24 h | 245 ± 82 | 182 ± 49 | 0.002 |
| 48 h | 265 ± 76 | 202 ± 46 | < 0.001 |
| 72 h | 290 ± 75 | 226 ± 65 | 0.002 |
| CT scan findings | |||
| GGO | 5 | 9 | 0.243 |
| DLA | 17 | 9 | |
| GGO + DLA | 2 | 9 | |
| Ventilator free days | 17.4 ± 9.1 | 11.5 ± 9.8 | 0.032 |
| ICU free days | 14.4 ± 9.1 | 10.0 ± 9.2 | 0.095 |
| 28-day mortality, n (%) | 4 (16.7) | 10 (37.0) | 0.127 |
| 90-day mortality, n (%) | 5 (20.8) | 13 (48.1) | 0.048 |
[i] NOTE. Plus-minus values are means ± standard deviation. Abbreviations: APACHE II, acute physiology and chronic health evaluation II; SOFA, sequential organ failure assessment; PEEP, positive end-expiratory pressure; GGO, ground-glass opacity; DLA, dorsal lung atelectasis.

Fig. 1
Comparison of weaning rates from mechanical ventilation between the prone and supine ventilation groups in patients with intra-abdominal sepsis-induced ARDS. Cumulative weaning rate over 28 days was compared using the log-rank test. ARDS: acute respiratory distress syndrome

Fig. 2
Comparison of weaning rates from mechanical ventilation between the prone and supine ventilation groups in patients with DLA findings (A) and GGO findings (B) on CT scan. Cumulative weaning rate from mechanical ventilation in each group was compared using the log-rank test. DLA: dorsal lung atelectasis; GGO: ground glass opacification; CT: computed tomography
Table 2
Demographic data of patients in whom CT scan shows dorsal lung atelectasis and ground glass opacification
| Dorsal Lung Atelectasis | Ground Glass Opacification | |||||
|---|---|---|---|---|---|---|
| Group A | Group B | p | Group A | Group B | p | |
| Number | 17 | 9 | 5 | 9 | ||
| Age (year-old) | 69.2 ±10.7 | 69.4 ±13.2 | 0.965 | 80.4 ±5.7 | 65.7 ±13.1 | 0.036 |
| Male / Female | 11/6 | 5 / 4 | 0.692 | 4 / 1 | 8 / 1 | 1.000 |
| APACHE II | 19.8 ±5.2 | 20.9 ±8.6 | 0.679 | 20.8 ±3.5 | 19.4 ±5.9 | 0.649 |
| SOFA | 7.5 ±3.5 | 8.4 ±3.6 | 0.512 | 7.4 ±1.9 | 6.3 ±2.5 | 0.435 |
| Surgical site | ||||||
| Upper tract | 6 | 3 | 5 | 4 | ||
| Lower tract | 10 | 6 | 0 | 5 | ||
| Miscellaneous | 1 | 0 | 0 | 0 | ||
| Drug therapy Steroid, n(%) | 2(11.7) | 2(22.2) | 0.591 | 2 (40.0) | 6 (66.7) | 0.580 |
| Ventilator settings at the start of the study FiO2 | 0.7 ±0.2 | 0.6± 0.2 | 0.239 | 0.7 ±0.2 | 0.7 ±0.1 | 0.884 |
| PEEP(cmH2O) | 9.8 ±1.0 | 9.0 ±4.7 | 0.515 | 12.0 ±4.7 | 9.1±1.1 | 0.093 |
| Peak pressure (cmH20) | 19.4 ±3.9 | 16.2 ±5.2 | 0.385 | 19.4 ±7.3 | 19.2 ±4.1 | 0.953 |
| Respiratory rate | 22.2 ±7.3 | 19.9 ±5.5 | 0.420 | 18.4 ±6.1 | 25.1 ±6.9 | 0.097 |
| PaO2/FiO2 | ||||||
| At the time after the start of the study | ||||||
| Oh | 157 ± 44 | 173 ±32 | 0.325 | 151 ±45 | 150 ±21 | 0.958 |
| 72 h | 307 ± 62 | 214 ±62 | 0.0010 | 233 ± 89 | 219 ±70 | 0.748 |
[i] Abbreviations: APACHE II, acute physiology and chronic health evaluation II; SOFA, sequential organ failure assessment; PEEP, positive end-expiratory pressure.
Table 3
Effect of prone ventilation on ventilator-free days, ICU-free days, and 28-day mortality in patients with CT SCAN findings of dorsal lung atelectasis or ground-glass opacification
| Dorsal Lung Atelectasis | Ground Glass Opacification | |||||
|---|---|---|---|---|---|---|
| Group A | Group B | Group A | Group B | |||
| Ventilator free days | 20.2 ±6.9 | 5.8 ±7.8 | < 0.001 | 7.8 ±11.0 | 11.9 ±10.3 | 0.390 |
| ICU free days | 16.9 ±7.5 | 4.1 ±7.2 | < 0.001 | 7.4 ±10.4 | 11.8 ±9.8 | 0.339 |
| 28-day mortality, n (%) | 1(5.9) | 4 (44.4) | 0.035 | 3 (60.0) | 4 (44.4) | 1.000 |
| 90-day mortality, n (%) | 2(11.8) | 5(55.6) | 0.028 | 3 (60.0) | 5(55.6) | 1.000 |